Mobile Menu

Generic Pharmaceutical Manufacturing in Washington

Author.Name IBISWorld United States Last Updated: April 2025 NAICS WA32541b

Generic Pharmaceutical Manufacturing in Washington industry analysis

The Generic Pharmaceutical Manufacturing industry in Washington is expected to grow an annualized x.x% to $x.x million over the five years to 2025, while the national industry will likely grow at x.x% during the same period. Industry establishments decreased an annualized -x.x% to xx locations. Industry employment has decreased an annualized -x.x% to xxx workers, while industry wages have decreased an annualized -x.x% to $x.x million.

Over the five years to 2030, the industry is expected to grow an annualized x.x% to $x.x million, while the national industry is expected to grow x.x%. Industry establishments are forecast to decline -x.x% to xx locations. Industry employment is expected to increase an annualized x.x% to xxx workers, while industry wages are forecast to increase % to $x.x million.

Unbiased research for even more industries at your fingertips

  • 5000+Industries covered
  • 100+Local analysts
  • 250k+Hours of detailed analysis
  • 100k+Subscriber community

Purchase a membership to access this industry and so much more.

About the Generic Pharmaceutical Manufacturing in Washington Market Research Report

What’s Included in the Generic Pharmaceutical Manufacturing in Washington Market Research Report

Definition of the Generic Pharmaceutical Manufacturing in Washington?

Generic pharmaceutical manufacturers produce medications that are bioequivalent to brand name drugs that regulatory agencies have already approved. Generic manufacturers create drugs that contain the same active ingredients, dosage form, strength and intended use as the original brand name drugs.

What’s included in the Generic Pharmaceutical Manufacturing in Washington?

The Generic Pharmaceutical Manufacturing in Washington includes developing and producing generic drugs, marketing and distributing generic drugs and gaining regulatory approval for generic drugs. Related terms covered in the Generic Pharmaceutical Manufacturing in Washington industry report includes a prescription drug produced by brand pharmaceutical companies and marketed under a private label at a generic product price, a large protein molecule derived from living sources, as opposed to a chemical substance. examples include insulin, human growth hormones and antibiotics, a drug derived from living organisms and marketed after the patent expiration of similar therapies. also known as flow-on biologics or biogenerics, an application filed for the approval of a new drug product. once approved, the product may be marketed in the united states and the period when numerous patents on blockbuster drugs are set to expire.

Industry Performance of the Generic Pharmaceutical Manufacturing industry in Washington

Benchmark the Generic Pharmaceutical Manufacturing in Washington industry performance with all WA county and national performance.

Generic Pharmaceutical Manufacturing in Washington

#19 in Highest Revenue 1% of state's GDP
Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

Generic Pharmaceutical Manufacturing in the US


Revenue (2025)
Annual Growth (2020-25)
Annual Growth (2025-30)

For the full list of industry drivers, see report purchase options.

Key Drivers of the Generic Pharmaceutical Manufacturing industry in Washington

See how key industry drivers, such as population, median houshold income, new business formation, total health expenditure, federal funding for medicare and medicaid and number of adults aged 65 and older are impacting Generic Pharmaceutical Manufacturing in Washington

Washington Economic Indicators

Population
Median Houshold Income
New Business Formation

View more economic information in WA State Economic profile

US Key External Drivers

Total health expenditure
Federal funding for Medicare and Medicaid
Number of adults aged 65 and older

For the full list of industry drivers, see report purchase options.

County Data of the Generic Pharmaceutical Manufacturing industry in Washington

Access proprietary data on county in the Generic Pharmaceutical Manufacturing in Washington, such as King County, Clark County and Snohomish County. Data includes figures on revenue, establishments, employees and wages by counties.

Key Statistics of the Generic Pharmaceutical Manufacturing industry in Washington

Download 18 years of historical data and 5 years of projected performance.

Need a deeper insight
Get a free tour

Free Tour

Top Questions Answered in this Report

Unlock comprehensive answers and precise data upon purchase. View purchase options.

What is the market size of the Generic Pharmaceutical Manufacturing industry in Washington in 2025?

The market size of the Generic Pharmaceutical Manufacturing industry in Washington is $478.5m in 2025.

How many businesses are there in the Generic Pharmaceutical Manufacturing industry in Washington in 2025?

There are 13 businesses in the Generic Pharmaceutical Manufacturing industry in Washington, which has been declining at an average annual rate of -1.5% from 2020 to 2025.

Has the Generic Pharmaceutical Manufacturing industry in Washington grown or declined over the past 5 years?

The market size of the Generic Pharmaceutical Manufacturing industry in Washington has been growing at an average annual rate of 1.2% from 2020 to 2025.

How many employees in the Generic Pharmaceutical Manufacturing industry in Washington in 2025?

There are 800 employees in the Generic Pharmaceutical Manufacturing industry in Washington, which has been declining at an average annual rate of -2.2% from 2020 to 2025.